BRIACELL THERAPEUTICS CORP (BCTX)

CA10778Y3023 - Common Stock

2.27  +0.01 (+0.44%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-1-31)
2023
(2023-7-31)
2022
(2022-7-31)
2021
(2021-7-31)
2020
(2020-7-31)
Revenue
0.000.000.000.000.00
Operating Expenses
31.72M23.27M15.29M6.98M3.56M
Research and Development
24.14M15.34M8.02M2.02M2.19M
Selling, General, and Administrative Expenses
7.57M7.94M7.27M4.96M1.35M
Operating Income
-31.72M-23.27M-15.29M-6.98M-3.56M
Interest Income/Expense
19.03M2.97M-11.55M-6.70M-39.76K
Other Income/Expense
N/A-0.000.000.00-58.22K
Non Recurring Items
N/A0.003.39K-138.01K21.05K
Income Before Taxes
-12.69M-20.30M-26.84M-13.82M-3.64M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-12.61M-20.30M-26.84M-13.82M-3.64M
EBITDA
-31.70M-23.26M-15.27M-6.96M-3.55M
 
Per Share Data
EPS Diluted Total Ops
-0.81-1.30-1.73-3.06-5.10
Non GAAP EPS
-1.67-1.30N/AN/AN/A
 
Statistics

All data in USD

Charts